Evidence map›Paper›PMID 34193293›Full record

ArticleAntimicrobial resistance and infection control2021

Combined antibiotic stewardship and infection control measures to contain the spread of linezolid-resistant Staphylococcus epidermidis in an intensive care unit.

Cihan Papan, Matthias Schröder, Mathias Hoffmann, Heike Knoll, Katharina Last, Frederic Albrecht, Jürgen Geisel, Tobias Fink, Barbara C Gärtner, Alexander Mellmann and 3 more

Abstract read
In one paragraph

Article in Antimicrobial resistance and infection control, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Staphylococcus massiliensis isolated from human blood cultures, Germany, 2017-2020.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Cihan PapanCenter for Infectious Diseases, Institute of Medical Microbiology and Hygiene, Saarland University, Kirrberger Strasse, Building 43, 66421, Homburg, Germany. cihan.papan@uks.eu.ORCID 0000-0001-7951-2567
Matthias SchröderDepartment of Anesthesiology, Intensive Care and Pain Therapy, Saarland University Medical Center, Homburg, Germany.
Mathias HoffmannHospital Pharmacy, Saarland University, Homburg, Germany.
Heike KnollDepartment of Anesthesiology, Intensive Care and Pain Therapy, Saarland University Medical Center, Homburg, Germany.
Katharina LastCenter for Infectious Diseases, Institute of Medical Microbiology and Hygiene, Saarland University, Kirrberger Strasse, Building 43, 66421, Homburg, Germany.
Frederic AlbrechtDepartment of Anesthesiology, Intensive Care and Pain Therapy, Saarland University Medical Center, Homburg, Germany.
Jürgen GeiselDepartment of Clinical Chemistry and Laboratory Medicine, Saarland University, Homburg, Germany.
Tobias FinkDepartment of Anesthesiology, Intensive Care and Pain Therapy, Saarland University Medical Center, Homburg, Germany.
Barbara C GärtnerCenter for Infectious Diseases, Institute of Medical Microbiology and Hygiene, Saarland University, Kirrberger Strasse, Building 43, 66421, Homburg, Germany.
Alexander MellmannInstitute of Hygiene, University Hospital Münster, Münster, Germany.
Thomas VolkDepartment of Anesthesiology, Intensive Care and Pain Therapy, Saarland University Medical Center, Homburg, Germany.
Fabian K BergerCenter for Infectious Diseases, Institute of Medical Microbiology and Hygiene, Saarland University, Kirrberger Strasse, Building 43, 66421, Homburg, Germany.
Sören L BeckerCenter for Infectious Diseases, Institute of Medical Microbiology and Hygiene, Saarland University, Kirrberger Strasse, Building 43, 66421, Homburg, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe unrestricted use of linezolid has been linked to the emergence of linezolid-resistant Staphylococcus epidermidis (LRSE). We report the effects of combined antibiotic stewardship and infection control measures on the spread of LRSE in an intensive care unit (ICU).

methodsMicrobiological data were reviewed to identify all LRSE detected in clinical samples at an ICU in southwest Germany. Quantitative data on the use of antibiotics with Gram-positive coverage were obtained in defined daily doses (DDD) per 100 patient-days (PD). In addition to infection control measures, an antibiotic stewardship intervention was started in May 2019, focusing on linezolid restriction and promoting vancomycin, wherever needed. We compared data from the pre-intervention period (May 2018-April 2019) to the post-intervention period (May 2019-April 2020). Whole-genome sequencing (WGS) was performed to determine the genetic relatedness of LRSE isolates.

resultsIn the pre-intervention period, LRSE were isolated from 31 patients (17 in blood cultures). The average consumption of linezolid and daptomycin decreased from 7.5 DDD/100 PD and 12.3 DDD/100 PD per month in the pre-intervention period to 2.5 DDD/100 PD and 5.7 DDD/100 PD per month in the post-intervention period (p = 0.0022 and 0.0205), respectively. Conversely, vancomycin consumption increased from 0.2 DDD/100 PD per month to 4.7 DDD/100 PD per month (p < 0.0001). In the post-intervention period, LRSE were detected in 6 patients (4 in blood cultures) (p = 0.0065). WGS revealed the predominance of one single clone.

conclusionsComplementing infection control measures by targeted antibiotic stewardship interventions was beneficial in containing the spread of LRSE in an ICU.

Indexed as

Antimicrobial StewardshipDrug Resistance, BacterialCross InfectionGermanyHumansInfection ControlIntensive Care UnitsLinezolidStaphylococcal InfectionsStaphylococcus epidermidisWhole Genome SequencingLinezolidAntimicrobial resistanceAntimicrobial stewardshipInfection controlLinezolidStaphylococciWhole-genome sequencing

Identifiers

PMID34193293
PMCPMC8242281

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.